SHAREHOLDER ALERT: Levi & Korsinsky Notifies Investors With Losses on Their
Investment in Wyeth of Class Action Lawsuit and the Deadline of June 11, 2013
to Seek a Lead Plaintiff Position -- PFE
NEW YORK, April 19, 2013 (GLOBE NEWSWIRE) -- Levi & Korsinsky announces that a
class action lawsuit has been commenced in the United States District Court
for the Southern District of New York on behalf of investors who acquired
Wyeth, now part of Pfizer, Inc. (NYSE:PFE) ("Wyeth" or "the Company") stock
between July 21, 2008 and July 29, 2008.
For more information, click here: http://9nl.it/wyeth/.
The complaint alleges that defendants violated securities laws by trading on,
and profiting from, material non-public information related to disappointing
clinical trial results for the drug bapineuzumab (AAB-001), an Alzheimer's
treatment that was being jointly developed by Wyeth and Elan Corporation, plc.
According to the complaint, defendants avoided approximately $40.4 million in
losses on their long positions and secured a $16 million profit from the short
positions opened the week before the July 29, 2008 disclosure of detailed
results of the clinical trial for bapineuzumab.
If you suffered a loss in Wyeth you have until June 11, 2013 to request that
the Court appoint you as lead plaintiff. Your ability to share in any recovery
doesn't require that you serve as a lead plaintiff. To obtain additional
information, contact Joseph E. Levi, Esq. either via email at firstname.lastname@example.org or
by telephone at (877) 363-5972, or visit http://9nl.it/wyeth/.
Levi & Korsinsky is a national firm with offices in New York, New Jersey and
Washington D.C. The firm has extensive expertise in prosecuting securities
litigation involving financial fraud, representing investors throughout the
nation in securities and shareholder lawsuits. Attorney advertising. Prior
results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP
Joseph Levi, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (866) 367-6510
Press spacebar to pause and continue. Press esc to stop.